Literature DB >> 19161927

Appropriate proton pump inhibitor use among older adults: a retrospective chart review.

Claudene J George1, Beatriz Korc, Joseph S Ross.   

Abstract

BACKGROUND: Proton pump inhibitors (PPIs) are widely used, but not always with a clear indication. Nonindicated use is of particular concern among older adults, who may have multiple comorbidities and take more medications, increasing their risk for adverse drug reactions.
OBJECTIVE: This study examined the appropriateness of PPI use at an outpatient geriatric practice and the association between particular patient characteristics and appropriate use of these medications.
METHODS: This was a retrospective chart review of a group of randomly identified community-dwelling adults aged >or=65 years with a current prescription for a PPI (as of August 2006) from a geriatric ambulatory care practice within an urban academic medical center. The main outcome was appropriateness of PPI use, categorized as indicated, possibly indicated, or not indicated, based on US Food and Drug Administration-approved indications and national gastroenterology guidelines.
RESULTS: Out of approximately 2500 patients in the geriatric practice, 702 (approximately 28%) were identified as having a current prescription for a PPI. From these, 110 charts were randomly selected for review, of which 10 were excluded based on predefined criteria. The sample was 79% female and 46% white, with a mean age of 82.8 years (range, 66-99 years). PPI use was indicated in 64% of these patients, possibly indicated in 7%, and not indicated in 29%. Compared with indicated PPI use, nonindicated use was significantly associated with use for <1 year (relative risk = 2.20; 95% CI, 1.00-4.86; P = 0.05). Nonindicated PPI use was not significantly associated with age, female sex, nonwhite race, or PPI initiation in the inpatient setting.
CONCLUSION: Almost 30% of patients receiving a PPI in this academic geriatric practice had no documented indication for PPI use.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19161927     DOI: 10.1016/j.amjopharm.2008.12.001

Source DB:  PubMed          Journal:  Am J Geriatr Pharmacother        ISSN: 1876-7761


  22 in total

Review 1.  Race/Ethnicity and overuse of care: a systematic review.

Authors:  Nancy R Kressin; Peter W Groeneveld
Journal:  Milbank Q       Date:  2015-03       Impact factor: 4.911

2.  Clinical and cost impact of intravenous proton pump inhibitor use in non-ICU patients.

Authors:  Soumana C Nasser; Jeanette G Nassif; Hani I Dimassi
Journal:  World J Gastroenterol       Date:  2010-02-28       Impact factor: 5.742

3.  Legacy Drug-Prescribing Patterns in Primary Care.

Authors:  Dee Mangin; Jennifer Lawson; Jessica Cuppage; Elizabeth Shaw; Katalin Ivanyi; Amie Davis; Cathy Risdon
Journal:  Ann Fam Med       Date:  2018-11       Impact factor: 5.166

4.  Variables associated with stress ulcer prophylaxis misuse: a retrospective analysis.

Authors:  Iyad A Issa; Ola Soubra; Hania Nakkash; Lama Soubra
Journal:  Dig Dis Sci       Date:  2012-03-17       Impact factor: 3.199

5.  Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study.

Authors:  Sascha Dublin; Rod L Walker; Michael L Jackson; Jennifer C Nelson; Noel S Weiss; Lisa A Jackson
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-08       Impact factor: 2.890

6.  Many patients continue using proton pump inhibitors after negative results from tests for reflux disease.

Authors:  Andrew J Gawron; Jami Rothe; Angela J Fought; Anita Fareeduddin; Erin Toto; Lubomyr Boris; Peter J Kahrilas; John E Pandolfino
Journal:  Clin Gastroenterol Hepatol       Date:  2012-02-22       Impact factor: 11.382

7.  Analysis of cytopenia in geriatric inpatients.

Authors:  G Röhrig; I Becker; K Pappas; M C Polidori; R J Schulz
Journal:  Z Gerontol Geriatr       Date:  2017-06-28       Impact factor: 1.281

8.  Low-Value Proton Pump Inhibitor Prescriptions Among Older Adults at a Large Academic Health System.

Authors:  John N Mafi; Folasade P May; Katherine L Kahn; Michelle Chong; Edgar Corona; Liu Yang; Margaret M Mongare; Vishnu Nair; Courtney Reynolds; Reshma Gupta; Cheryl L Damberg; Eric Esrailian; Catherine Sarkisian
Journal:  J Am Geriatr Soc       Date:  2019-09-05       Impact factor: 5.562

9.  Cost reduction associated with restriction policy on dispensing intravenous esomeprazole in Lebanon.

Authors:  Soumana C Nasser; Jeanette G Nassif; Fouad Mahfouz
Journal:  Pharm World Sci       Date:  2010-11-04

10.  Proton pump inhibitor prescriptions and subsequent use in US veterans diagnosed with gastroesophageal reflux disease.

Authors:  Andrew J Gawron; John E Pandolfino; Scott Miskevics; Sherri L Lavela
Journal:  J Gen Intern Med       Date:  2013-07       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.